Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Adrabetadex
Therapeutic Area : Rare Diseases and Disorders
Study Phase : Phase II/ Phase III
Sponsor : INPDR
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The partnership will provide Mandos Health with real-world evidence that will directly inform the development of its Niemann-Pick type C1 (NPC1) investigational product, VTS-270 (adrabetadex).
Brand Name : VTS-270
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 16, 2023
Lead Product(s) : Adrabetadex
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase II/ Phase III
Sponsor : INPDR
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?